Synfini
PrivateLast Round
VC Round
Jul 7, 2025
Total Funding Raised
$41M
Company Overview
Synfini operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a VC Round in July 2025.
Synfini is a biotechnology company that offers an AI-driven drug discovery platform aimed at accelerating the design, development, and synthesis of new therapeutics through the use of integrated neuro-symbolic AI, robotic automation, and comprehensive chemistry data.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synfini Comparables
Compare Synfini with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Excelsior Sciences | 84% | |
| Iktos | 83% | |
| Chemify | 83% |
For institutional investors. Book with your work email.
Synfini Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 7, 2025 | ||||
| Grant | Sep 26, 2023 | ||||
| Seed | Sep 26, 2023 |
For institutional investors. Book with your work email.
Synfini Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | VC Round, Seed |
| JSL Health Capital | VC Round |
| Foothill Ventures | VC Round |
| High Water Venture Partners | VC Round |
| SRI Ventures | VC Round, Seed |
| Ferocity Capital | VC Round |
| WERU Investment Co. | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Launched Fast Pass I, an open, rapid cloud workflow system.
- Oct 23, 2025
Selected for the Innovation AveNEW showcase at SLAS 2026.
For institutional investors. Book with your work email.
Synfini Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synfini's valuation, stock price, and market status.
Is Synfini a public or private company?
Synfini is a private company.
What is the current stock price of Synfini?
Synfini is a private company, so its shares have no public market price. Caplight tracks Synfini's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synfini worth (valuation)?
Valuation information for Synfini is not publicly available.
Can I buy Synfini stock?
Synfini shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synfini's last funding round?
Synfini's most recent funding round was VC Round on July 7, 2025.
Who are the main investors in Synfini?
Key investors in Synfini include JSL Health Capital.
Will Synfini IPO soon?
No public IPO plans have been announced for Synfini.
How can I track Synfini secondary market activity?
Caplight tracks bids, offers, and trades in Synfini's shares on secondary markets.